Psychedelic “Therapy” and the Catholic Soul: A Dangerous Naivety
EWTN News reports on Catholic mental health professionals welcoming the Trump administration’s executive order to accelerate research and access to psychedelic drugs for mental illness, while urging “caution.” The article presents a hopeful outlook on substances like ibogaine and psilocybin, highlighting their potential to “rewire” neural pathways and offer “real healing” for conditions like depression and PTSD. While acknowledging potential dangers, the professionals emphasize the need for “protective factors” and “Catholic anthropology” to guide treatment, viewing these substances as tools for “stewardship over our life” and “maintaining the temple of our body.” This approach, however, fundamentally misunderstands the nature of the human person, the etiology of suffering, and the Church’s timeless teaching on the integrity of the soul and the dangers of altering consciousness outside of strictly controlled medical necessity. The enthusiasm for such “innovative methods” reflects a capitulation to a materialistic, reductionist view of the human person, neglecting the primacy of the spiritual and the profound risks posed to the soul by substances known to induce altered states of consciousness and ego dissolution.








